Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/9537
Title: Blinded, Double-Dummy, Parallel-Group, Phase 2a Randomized Clinical Trial to Evaluate the Efficacy and Safety of a Highly Selective 5-Hydroxytryptamine Type 4 Receptor Agonist in Critically Ill Patients With Enteral Feeding Intolerance
Authors: Chapman, M.J.
Jones, K.L.
Almansa, C.
Barnes, C.N.
Nguyen, D.
Deane, A.M.
Issue Date: 2020
Journal: Journal of Parenteral and Enteral Nutrition
Appears in Sites:Publication workflow
Queensland Health Publications

Show full item record

Page view(s)

2
checked on Jul 10, 2025

Google ScholarTM

Check


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.